Article Information
History
- December 26, 2021.
Article Versions
- Version 1 (December 18, 2021 - 09:49).
- Version 2 (December 20, 2021 - 09:25).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Xiaoqi Yu1,+,
- Dong Wei1,+,
- Wenxin Xu1,+,
- Yulong Li1,
- Xinxin Li1,
- Xinxin Zhang1,2,*,†,
- Jieming Qu3,4,5,*,
- Zhitao Yang6,* and
- Erzhen Chen6,*
- 1Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 2Clinical Research Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 3Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 4Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 5Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai, China
- 6Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- ↵†Correspondence: Xinxin Zhang, Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China, Email zhangx{at}shsmu.edu.cn
Posted December 26, 2021.
Reduced sensitivity of SARS-CoV-2 Omicron variant to booster-enhanced neutralization
